These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38506227)

  • 1. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
    Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
    Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent imaging using novel conjugated polymeric nanoparticles-affimer probes in complex
    Jolugbo P; Willott T; Lin WH; Maisey T; O'Callaghan D; Green MA; Jayne DG; Khot MI
    Nanoscale; 2023 Aug; 15(30):12476-12480. PubMed ID: 37466243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
    Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
    da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
    Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
    Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
    Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models.
    Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA
    Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models.
    Elekonawo FMK; Bos DL; Goldenberg DM; Boerman OC; Rijpkema M
    EJNMMI Res; 2019 Dec; 9(1):108. PubMed ID: 31828541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
    Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
    Pereira I; Sousa F; Kennedy P; Sarmento B
    Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
    Guadagni F; Tortora G; Roselli M; Clair T; Cho-Chung YS; Schlom J; Greiner JW
    Int J Cancer; 1991 May; 48(3):413-22. PubMed ID: 1645700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
    Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
    Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
    Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
    Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G; Chambrier I; Cook MJ; Russell DA
    Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts.
    Urva SR; Balthasar JP
    MAbs; 2010; 2(1):67-72. PubMed ID: 20081377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
    Lee JH; Lee SW
    Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
    Wu R; Yow C; Law E; Chu E; Huang Z
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101945. PubMed ID: 32768589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
    Levin LV; Griffin TW
    Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
    Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
    J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab-Ag
    Hashemkhani M; Demirci G; Bayir A; Muti A; Sennaroglu A; Mohammad Hadi L; Yaghini E; Loizidou M; MacRobert AJ; Yagci Acar H
    Nanoscale; 2021 Sep; 13(35):14879-14899. PubMed ID: 34533177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.